首页> 外文期刊>Gastrointestinal Endoscopy >A risk index for advanced neoplasia on the second surveillance colonoscopy in patients with previous adenomatous polyps
【24h】

A risk index for advanced neoplasia on the second surveillance colonoscopy in patients with previous adenomatous polyps

机译:先前有腺瘤性息肉的患者在第二次结肠镜检查中晚期肿瘤形成的危险指数

获取原文
获取原文并翻译 | 示例
           

摘要

Background Predicting the risk of advanced colorectal neoplasia on the second surveillance colonoscopy could help tailor surveillance. Objective To derive and validate a risk index for advanced neoplasia on the second surveillance colonoscopy. Design Retrospective cohort. Setting Single-specialty practice; Veterans Affairs Medical Center. Patients A total of 965 patients with baseline adenomatous polyps, 2 surveillance colonoscopies, and no reported family history of colorectal cancer; validation cohort of 372. Interventions Multivariable logistic regression including demographics and previous colonoscopy results; derivation and validation of a risk index. Main Outcome Measurements Advanced adenoma (≥1 cm in size, villous histology, or high-grade dysplasia) on the second surveillance colonoscopy. Results Mean age was 57.8 ± 9.8 years, 62% were men, and 36% had an advanced adenoma on the index colonoscopy. Associated with advanced adenoma on the second surveillance colonoscopy were age at index colonoscopy (scored 0 for younger than 55 years of age, 1 for 55-59 years of age, 2 for 60-64 years of age, and 3 for older than 65 years of age) and previous findings (non-neoplastic, nonadvanced, advanced [scored 0, 1, and 2, respectively]) on index colonoscopy and the first surveillance colonoscopy, with scores ranging from 1 to 7. Risks of advanced adenoma on the second surveillance colonoscopy with scores of 5 or less and more than 5 were 4.8% (95% confidence interval, 3.5%-6.4%) and 14.9% (95% confidence interval, 7.4%-25.7%), respectively, comprising 93% and 7%, respectively, of the cohort. Corresponding results in the validation cohort were 5.6% and 19.2%, respectively, comprising 86.1% and 13.9%, respectively, of the cohort. Limitations Retrospective study with potential for selection bias. Conclusion This index stratifies the risk of advanced adenoma on the second surveillance colonoscopy. If validated independently, it may be useful for tailoring surveillance.
机译:背景技术在第二次监测结肠镜检查中预测晚期大肠肿瘤的风险可能有助于定制监测。目的在第二次监测结肠镜检查中获得并验证晚期肿瘤的风险指数。设计回顾性队列。设置单一专业实践;退伍军人事务医疗中心。患者共有965例基线腺瘤性息肉,2例结肠镜检查且未报告大肠癌家族史。 372个验证队列。干预多变量logistic回归,包括人口统计学和以前的结肠镜检查结果;风险指数的推导和验证。主要结果测量在第二次结肠镜检查中发现晚期腺瘤(大小≥1 cm,绒毛组织学或高度不典型增生)。结果指数结肠镜检查的平均年龄为57.8±9.8岁,男性为62%,晚期腺瘤为36%。在第二次结肠镜检查中与晚期腺瘤相关的是指数结肠镜检查的年龄(55岁以下为0,55-59岁为1,60-64岁为2,65岁以上为3。年龄和先前在结肠镜检查和第一次监测结肠镜检查中发现的结果(非肿瘤,不进展,晚期[分别为0、1和2]),评分范围为1到7。第二次出现晚期腺瘤的风险得分小于或等于5且大于5的监测结肠镜检查分别为4.8%(95%置信区间,3.5%-6.4%)和14.9%(95%置信区间,7.4%-25.7%),分别为93%和7分别占同类群组的%。验证队列的相应结果分别为5.6%和19.2%,分别占队列的86.1%和13.9%。局限性回顾性研究具有选择偏倚的潜力。结论该指数对第二次监测结肠镜检查的晚期腺瘤风险进行了分层。如果独立验证,则可能对定制监视很有用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号